Scott A. Rodeo, MD, FAAOS, of the Hospital for Special Surgery (HSS) in New York City has been awarded the first OREF/AAOS Injectable Orthobiologics of Knee Osteoarthritis Grant, the Orthopaedic Research and Education Foundation (OREF) announces.

Rodeo, who is an Attending Orthopedic Surgeon and Clinician-Scientist at HSS, with appointments in the Department of Orthopedic Surgery (Sports Medicine Institute) and the Research Department (Tissue Engineering, Repair, and Regeneration Program), will serve as principal investigator for the study, “PRP Treatment of the ACL-Injured Knee to Decrease the Risk of PTOA.”

Funding for this grant was made possible through the OREF/AAOS Clinical Research Gaps Fund with contributions from the American Academy of Orthopaedic Surgeons (AAOS) and individual donors, according to a media release.

First Grant from OREF/AAOS Partnership

The $50,000 grant is the first to be awarded as part of a strategic partnership between OREF and AAOS which aims to help narrow the gap between clinical research funding and prioritized clinical research needs in musculoskeletal care, including orthobiologics.

The partnership identifies areas of clinical research for which there is a need for increased, targeted funding to evaluate the effectiveness of various orthopaedic interventions and ultimately improve the quality of care for patients. A request for applications (RFA) is expected to be published in November 2021 for the second grant to be funded through this partnership.

“We are excited to fund the first grant in what we hope will be a long-term partnership to close gaps in our clinical knowledge of how to treat musculoskeletal issues that adversely affect both the patient and society. The physical and economic burden of musculoskeletal disease is enormous, but without a clear understanding of the problem and the resources to explore potential solutions, that burden will grow unchecked.”

— Richard F. Kyle, MD, FAAOS, OREF president

“This particular study of the use of an injectable orthobiologic, PRP, of a common knee ligament injury may lend insight into treatments to either prevent or minimize the later development of osteoarthritis of the knee. The Academy is delighted to participate in this inaugural research endeavor. We are confident that the OREF/AAOS Clinical Research Gaps Fund will build momentum and that our collaborative efforts will help promote the highest quality of musculoskeletal care for the patients we serve.”

— Daniel K. Guy, MD, FAAOS, AAOS president

[Source(s): Orthopaedic Research and Education Foundation, PRWeb]

Related Content:
PRP Injection and Physical Therapy for Hamstring Injury: Better Together or Apart?
How Does Platelet-Rich Plasma Therapy Affect the Risk of Meniscus Repair Failure?
AMSSM Awards $300K Grant to Study Knee Osteoarthritis Treatment